Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
NeuroPace, which has developed implantable devices to treat neurological disorders, disclosed on Tuesday it has raised about $18 million of a planned $50 million in new funding. The Mountain View company led by CEO Frank Fischer didn’t say on its Securities and Exchange Commission filing who has invested so far. It indicated there are 20 backers in the round to date. NeuroPace has raised about $180 million since it was founded in 1997. Its backers include New Enterprise Associates, InterWest Partners, Johnson & Johnson Development Corp., Kleiner Perkins Caufield & Byers, MedVenture Associates, Technology Venture Partners and Domain Associates.
Help employers find you! Check out all the jobs and post your resume.
